Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs.
AUTOR(ES)
Ling, N
RESUMO
In the myenteric plexus-longitudinal muscle bioassay, beta-endorphin, i.e., beta-lipotropin (beta-LPH)-[61-91], has a potency of 450 with confidence limits of 281-966 when Met5-enkephalin is used as a reference standard with a potency of 100. The primary amide and the ethylamide of Met5-enkephalin have potencies statistically overlapping with that of beta-endorphin. The primary amide of alpha-endorphin has twice the potency of the free acid form of alpha-endorphin. An intact NH2-terminal tyrosine is not necessary for full intrinsic activity. The shortest fragment of beta-LPH with morphinomimetic activity is beta-LPH-[61-64].
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=431021Documentos Relacionados
- beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins.
- Processing of the precursor to corticotropin and beta-lipotropin in humans.
- Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin.
- Biosynthesis of beta-endorphin from beta-lipotropin and a larger molecular weight precursor in rat pars intermedia.
- Characterization of a common precursor to corticotropin and beta-lipotropin: identification of beta-lipotropin peptides and their arrangement relative to corticotropin in the precursor synthesized in a cell-free system.
